Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy.

@article{Ferreri2006CognitiveDI,
  title={Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy.},
  author={Florian Ferreri and Catherine Agbokou and Serge Gauthier},
  journal={Journal of psychiatry & neuroscience : JPN},
  year={2006},
  volume={31 6},
  pages={369-76}
}
OBJECTIVE In schizophrenia, cognitive dysfunctions commonly affect attention, memory and executive function, interfere with functional outcome and remain difficult to treat. Previous studies have implicated the cholinergic system in cognitive functioning. In Alzheimer's disease, cholinergic agonists have shown modest clinical benefits on cognitive and behavioural symptoms. Impaired cholinergic activity might also be involved in schizophrenia. Hence the role of cholinesterase inhibitors (ChEI… CONTINUE READING
13 Citations
84 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 84 references

Cognitive performance in patients with schizophrenia after rivastigmine treatment [abstract

  • S Chouinard, J Poulin, E Stip
  • J Clin Psychopharmacol
  • 2005

Similar Papers

Loading similar papers…